Antibody response against Ebola VP40 matrix protein was evaluated in a similar ELISA using recombinant EBOV VP40 matrix protein produced by a recombinant baculovirus in insect cells.
to stimulate PBMCs for 6 hours. The VSV∆G-ZEBOV vaccine encodes the Zaire EBOV GP from the Kikwit strain. Cytokine-positive cells were defined as a percentage within CD4 + or CD8 + T cells that produced IFN-γ, IL-2, and/or TNF-α.
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Real-time reverse transcription polymerase chain reaction (rRT-PCR) assay. Zaire Ebola virus glycoprotein (GP) RNA was detected with the EZ1 rRT-PCR; and Ebola nucleoprotein (NP) RNA was detected with an NP-specific rRT-PCR using the methods as previously described 8, 9 . rVSV detection was done by rRT-PCR targeting VSV nucleoprotein (N) based on a previously published protocol 9 using a different primer set (forward primer: CGGAGGATTGACGACTAATGC; reverse primer: CGAGCCATTCGACCACATC). These assays were performed using Applied The numbers presented in the table are the detected protein absolute levels in pg/ml for days 2, 4, 9, 17 and 34. Pre-vaccination plasma was unavailable, thus the day 34 levels may serve as a best available baseline. Also, plasma from an irrelevant normal control was evaluated (the far right column, blue highlight). Some of these plasma proteins may have been down regulated in response to the vaccine, but this is unknown since prevaccination plasma was unavailable. 
